Quest Podcasts

posted on June 25, 2013 - 11:00am

A seven-minute discussion with Jon Lindstrom, a neuroscientist at the University of Pennsylvania who studies myasthenia gravis (MG).

MDA research grantee Jon Lindstrom talked with MDA Medical and Science Editor Maggie Wahl on June 6, 2013, about his discovery of the...

A 15-minute discussion with Douglas Kerr, director of Neurodegeneration Clinical Research at Biogen Idec

posted on January 15, 2013 - 2:24pm

Douglas Kerr of the biotech firm Biogen Idec spoke with MDA Executive Vice President of Research and Medical Director Valerie Cwik on Jan. 11, 2013, about the company’s recent decision to stop development of dexpramipexole for amyotrophic lateral sclerosis, after the drug showed no efficacy in a 943-person, phase 3 clinical trial. This podcast complements...

A 12-minute discussion with Michael Rudnicki, a molecular biologist who studies muscle repair and regeneration at Ottawa Hospital Research Institute
posted on December 20, 2012 - 9:54am

MDA research grantee Michael Rudnicki talked with MDA on Dec. 17, 2012, about how the WNT7a protein increased the numbers of muscle repair cells and the size and strength of muscle fibers in a mouse model of Duchenne muscular dystrophy. Rudnicki also discussed the advantages and...

A 12½-minute discussion with Emanuela Gussoni, a molecular biologist at Boston Children's Hospital
posted on July 10, 2012 - 10:02am

MDA research grantee Emanuela Gussoni talked with MDA Medical and Science Editor Margaret Wahl on June 27, 2012, about the development of stem-cell-based treatments for muscular dystrophies. This podcast complements the June 14, 2012, Quest News story Stem Cell Briefs: Contributions of PAX7, S1P, MCAM.

An 11-minute discussion with Howard Worman, a professor of medicine and pathology and cell biology at Columbia University Medical Center in New York.
posted on May 30, 2012 - 4:12pm

MDA research grantee Howard Worman talked with MDA Medical and Science Editor Margaret Wahl on May 23, 2012, about his group's new ideas for treating the cardiac abnormalities associated with lamin A/C mutations, which can cause one type of Emery-Dreifuss MD or the type 1B form of limb-girdle muscular dystrophy (LGMD1B).

This podcast complements...

A 13½-minute discussion with Matthew Disney, a biochemist at the Scripps Research Institute in Jupiter, Fla.
posted on March 9, 2012 - 2:54pm

MDA research grantee Matthew Disney talked with MDA Medical and Science Editor Margaret Wahl on Feb. 27, 2012, about his group's experiments using small molecules that target toxic RNA in type 1 myotonic dystrophy.

This podcast complements MMD1: Synthetic 'H' Molecules Lock Up Toxic Repeats.

An 11½-minute discussion with neurologist and molecular geneticist Stephen Tapscott at the Fred Hutchinson Cancer Research Center in Seattle
posted on January 31, 2012 - 12:35pm

Stephen Tapscott talked with MDA Medical and Science Editor Margaret Wahl on Jan. 23, 2012, about how inappropriate expression of the DUX4 protein in skeletal muscle may lead to facioscapulohumeral muscular dystrophy (FSHD). This podcast complements DUX4 Causes Muscle Mayhem in FSHD.